… Clinical profile and prognostic significance of natriuretic peptide trajectory following
hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial. Eur J Heart …

… Direct stimulators of sGC differ from other agents targeting the cGMP pathway in … of worsening
chronic heart failure (HF) requiring hospitalization where, after discharge, cardiovascular …

… Evaluating sGC stimulators in a trial with a longer follow-up in patients without worsening heart
failure … Moreover, the potential anti-remodelling effects of sGC stimulators may reduce the …

… The clinical outcomes for patients with worsening chronic heart failure (WCHF) remain …
cyclase (sGC) stimulators target reduced cGMP generation due to insufficient sGC stimulation …

… cyclase stimulators have significant benefits in reducing hospitalizations in patients with heart
failure with … Poor response to natriuretic peptides leads to worsening of the vicious cycle of …

… SOCRATES-REDUCED indicated that among patients with worsening chronic HF (LVEF
≤ 45%), it is suggested that a dose–response relationship that higher vericiguat doses were …

… for heart failure (HF), the survival period of patients has been extended. However, the
emergence of some patients with repeated hospitalizations due to their worsening conditions and …

… in the setting of worsening chronic heart failure. The nitric … guanylate cyclase stimulator in
heart failure patients with preserved … guanylate cyclase stimulator in heart failure patients with …

… trials involved patients recently hospitalized with worsening HF, a time during which renal
… In addition, patients with worsening chronic HF (such as those enrolled in the SOCRATES …

… of HF, with New York Heart Association (NYHA) functional … clinical stability of worsening
chronic HF requiring hospitalization or … concluded that in patients with worsening chronic HF and …